Neuronetics Overcomes Negative Panel Review To Earn Clearance For NeuroStar

FDA cleared Neuronetics' NeuroStar transcranial magnetic stimulation system for drug-resistant depression, despite a negative advisory panel review, based on a pivotal study subset analysis